Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: A 10-year-experience

Objective: To review outcomes of pregnancy termination between 14-32 weeks of gestation based on a10-year-experience of misoprostol use at Maharaj Nakorn Chiang Mai Hospital. Study design: A retrospective, descriptive study Material and Method: Based on the authors' prospective database, all pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Pongsatha S., Tongsong T.
Format: Article
Language:English; Thai
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-79961197103&partnerID=40&md5=e2e926397a77c6bc5063a557f86f91f7
http://www.ncbi.nlm.nih.gov/pubmed/21863669
http://cmuir.cmu.ac.th/handle/6653943832/2949
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English; Thai
id th-cmuir.6653943832-2949
record_format dspace
spelling th-cmuir.6653943832-29492014-08-30T02:25:35Z Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: A 10-year-experience Pongsatha S. Tongsong T. Objective: To review outcomes of pregnancy termination between 14-32 weeks of gestation based on a10-year-experience of misoprostol use at Maharaj Nakorn Chiang Mai Hospital. Study design: A retrospective, descriptive study Material and Method: Based on the authors' prospective database, all pregnancy terminations by misoprostol between 14-32 weeks of gestation between 1998 and 2008 were reviewed. The main outcomes included success rate of termination, mean induction-to-abortion time, and complication rate. In addition, regimens and routes of drug administration as well as indications for termination of pregnancy were also analyzed. Results: Seven hundred forty one pregnancy terminations were performed using misoprostol with dosage varied from 50 mcg to 800 mcg, mostly 400 mcg intravagina every three hours. The most common indication for pregnancy termination was severe fetal thalassemia (35.8%). The majority of cases were pregnancies with live fetuses and only 18.2% were associated with a dead fetus in utero. Success rate of termination within 48 hours was 85.9%. Pregnancies with previous cesarean section accounted for 8.6% of cases. The mean gestational age was 20.94 weeks. The mean abortion time was 25.35 hours, ranging from 1.25 to 247.88 hours. The two most common adverse effects were chill and fever (43.7% and 34.3%). The rate of analgesia needed was 39.3%. No serious adverse complications such as uterine rupture were found. Conclusion: This experience suggests that misoprostol has a high efficacy for pregnancy termination with acceptable minor side effects and it is relatively safe when used with precaution. 2014-08-30T02:25:35Z 2014-08-30T02:25:35Z 2011 Article 1252208 21863669 JMTHB http://www.scopus.com/inward/record.url?eid=2-s2.0-79961197103&partnerID=40&md5=e2e926397a77c6bc5063a557f86f91f7 http://www.ncbi.nlm.nih.gov/pubmed/21863669 http://cmuir.cmu.ac.th/handle/6653943832/2949 English; Thai
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English; Thai
description Objective: To review outcomes of pregnancy termination between 14-32 weeks of gestation based on a10-year-experience of misoprostol use at Maharaj Nakorn Chiang Mai Hospital. Study design: A retrospective, descriptive study Material and Method: Based on the authors' prospective database, all pregnancy terminations by misoprostol between 14-32 weeks of gestation between 1998 and 2008 were reviewed. The main outcomes included success rate of termination, mean induction-to-abortion time, and complication rate. In addition, regimens and routes of drug administration as well as indications for termination of pregnancy were also analyzed. Results: Seven hundred forty one pregnancy terminations were performed using misoprostol with dosage varied from 50 mcg to 800 mcg, mostly 400 mcg intravagina every three hours. The most common indication for pregnancy termination was severe fetal thalassemia (35.8%). The majority of cases were pregnancies with live fetuses and only 18.2% were associated with a dead fetus in utero. Success rate of termination within 48 hours was 85.9%. Pregnancies with previous cesarean section accounted for 8.6% of cases. The mean gestational age was 20.94 weeks. The mean abortion time was 25.35 hours, ranging from 1.25 to 247.88 hours. The two most common adverse effects were chill and fever (43.7% and 34.3%). The rate of analgesia needed was 39.3%. No serious adverse complications such as uterine rupture were found. Conclusion: This experience suggests that misoprostol has a high efficacy for pregnancy termination with acceptable minor side effects and it is relatively safe when used with precaution.
format Article
author Pongsatha S.
Tongsong T.
spellingShingle Pongsatha S.
Tongsong T.
Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: A 10-year-experience
author_facet Pongsatha S.
Tongsong T.
author_sort Pongsatha S.
title Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: A 10-year-experience
title_short Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: A 10-year-experience
title_full Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: A 10-year-experience
title_fullStr Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: A 10-year-experience
title_full_unstemmed Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: A 10-year-experience
title_sort outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: a 10-year-experience
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-79961197103&partnerID=40&md5=e2e926397a77c6bc5063a557f86f91f7
http://www.ncbi.nlm.nih.gov/pubmed/21863669
http://cmuir.cmu.ac.th/handle/6653943832/2949
_version_ 1681419956125696000